Other viral illnesses - SAVIMS

Other viral illnesses, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Overview of Clinical Development for Vaccines

Director | 14/08/2015 | Other viral illnesses, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Singh, K., & Mehta, S. (2016). The clinical development process for a novel preventive vaccine: An overview. Journal of Postgraduate Medicine, 62(1), 4–11. https://doi.org/10.4103/0022-3859.173187 Summary: The article provides a comprehensive overview of the clinical development process for novel preventive vaccines, detailing the essential phases of vaccine trials: Phase I, II, and III. It highlights […]

Other scientific evidence, Other viral illnesses, Resource Type, Treatment, Viral illnesses

Understanding RNA: The Unsung Hero of Genetic Material

Director | 26/06/2013 | Other scientific evidence, Other viral illnesses, Resource Type, Treatment, Viral illnesses

Reference: Crossley, M. (2021). Explainer: what is RNA? The Conversation. https://theconversation.com/explainer-what-is-rna-151691 Summary: RNA (ribonucleic acid) is a crucial molecule in the biological world, serving multiple roles beyond that of genetic material. While DNA is stable and well-known, RNA is less stable due to an extra oxygen atom, allowing it to function as a messenger that

Antigenic vaccines, General Health, Immunology, Other viral illnesses, Peer-reviewed evidence, Reference Library, Resource Type, Vaccines, Viral illnesses

Immunologic Activity and Safety of Autologous HIV RNA–Electroporated Dendritic Cells in HIV-1 Infected Patients

Director | 01/02/2011 | Antigenic vaccines, General Health, Immunology, Other viral illnesses, Peer-reviewed evidence, Reference Library, Resource Type, Vaccines, Viral illnesses

Reference: Routy, J.-P., Boulassel, M.-R., Yassine-Diab, B., Nicolette, C., Healey, D., Jain, R., Landry, C., Yegorov, O., Tcherepanov, I., Monesmith, T., Finke, L., & Sékaly, R.-P. (2010). Immunologic activity and safety of autologous HIV RNA–electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy. Clinical Immunology, 134(2), 140. https://doi.org/10.1016/j.clim.2009.09.009 Summary: This pilot study assessed the

General Health, Immunology, Other viral illnesses, Peer-reviewed evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

Immunosuppression After Measles Vaccination

Director | 01/02/1994 | General Health, Immunology, Other viral illnesses, Peer-reviewed evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Smedman, L., Joki, A., da Silva, A. P., Troye-Blomberg, M., Aronsson, B., & Perlmann, P. (1994). Immunosuppression after measles vaccination. Acta Paediatrica, 83(2), 164-168. https://doi.org/10.1111/j.1651-2227.1994.tb13043.x Summary: The study investigates the effects of live attenuated measles vaccination on cellular immune responses in children from Sweden and Guinea-Bissau. Sixteen children from each region were assessed before